AUTOLOGOUS CYTOKINE-INDUCED KILLER (CIK) IMMUNOTHERAPY IN A CASE OF DISSEMINATED TUBERCULOSIS

被引：0

作者：

Xu, Ping ^{[1
]}

Xu, Jun-Chi ^{[1
]}

Chen, Xin-Nian ^{[1
]}

Ye, Zhi-Jian ^{[1
]}

Wu, Mei-Ying ^{[1
]}

机构：

[1] Fifth Peoples Hosp Suzhou, Suzhou 215000, Jiangsu, Peoples R China

来源：

SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES | 2015年 / 32卷 / 01期

关键词：

CIK; disseminated tuberculosi; immunotherapy; PHASE-I; CELLS; LYMPHOMA; TRIAL; VIVO;

D O I：

暂无

中图分类号：

R56 [呼吸系及胸部疾病];

学科分类号：

摘要：

A 23-year-old woman had dry cough, fever and chest tightness for 1 months. Through thoracic CT scan and serological examination, the patient was clinically diagnosed as disseminated tuberculosis. she was given anti-tuberculosis therapy combined with autologous cytokine-induced killer (CIK) immunotherapy. Through the close follow-ups we found that after immunotherapy Her condition would have a swift improvement and she do not appear liver damage after a large doses of antibiotic therapy. In conclusion, adjuvant autologous CIK immunotherapy is an effective approach for disseminated tuberculosis.

引用

页码：83 / 86

页数：4

共 50 条

[41] Phase III randomized trial of autologous cytokine-induced killer cell immunotherapy for newly diagnosed glioblastoma in korea
Kong, Doo-Sik
Nam, Do-Hyun
Kang, Shin-Hyuk
Lee, Jae Won
Chang, Jong-Hee
Kim, Jeong-Hoon
Lim, Young-Jin
Koh, Young-Cho
Chung, Yong-Gu
Kim, Jae-Min
Kim, Choong-Hyun
ONCOTARGET, 2017, 8 (04) : 7003 - 7013
[42] Cytokine-induced killer (CIK) cell therapy for patients with hepatocellular carcinoma: efficacy and safety
Yue Ma
Ying-Chun Xu
Lei Tang
Zan Zhang
Jian Wang
Hong-Xia Wang
Experimental Hematology & Oncology, 1 (1)
[43] Autologous cytokine-induced killer cell immunotherapy may improve overall survival in advanced malignant melanoma patients
Zhang, Yong
Zhu, Yu'nan
Zhao, Erjiang
He, Xiaolei
Zhao, Lingdi
Wang, Zibing
Fu, Xiaomin
Qi, Yalong
Ma, Baozhen
Song, Yongping
Gao, Quanli
IMMUNOTHERAPY, 2017, 9 (14) : 1165 - 1174
[44] PHASE III RADOMIZED TRIAL OF AUTOLOGOUS CYTOKINE-INDUCED KILLER CELL IMMUNOTHERAPY FOR NEWLY DIAGNOSED GLIOBLASTOMA IN KOREA
Kim, C.
Nam, D.
Kong, D.
Kang, S.
Jang, J.
Kim, J.
Lim, Y.
Koh, Y.
Chung, Y.
Kim, J.
NEURO-ONCOLOGY, 2017, 19 : 19 - 19
[45] Cytokine-induced killer cells/dendritic cells and cytokine-induced killer cells immunotherapy for the treatment of esophageal cancer in China: a meta-analysis
Liu, Yan
Mu, Ying
Zhang, Anqi
Ren, Shaoda
Wang, Weihua
Xie, Jiaping
Zhang, Yingxin
Zhou, Changhui
ONCOTARGETS AND THERAPY, 2017, 10 : 1897 - 1908
[46] Immunotherapy with cytokine-induced killer cells in patients with refractory solid tumours
Pierelli, L.
Iudicone, P.
Bonanno, G.
Vacca, M.
Ipsevich, F.
Fioravanti, D.
Lavorino, C.
Foddai, M. L.
Gentili, S.
Urso, P.
Pandolfi, A.
Scocchera, R.
Rutella, S.
Scambia, G.
BONE MARROW TRANSPLANTATION, 2011, 46 : S330 - S330
[47] NEW ATTEMPT IN TUBERCULOSIS TREATMENT: AUTOLOGOUS CYTOKINE-INDUCED KILLER AFTER CHEMOTHERAPY TREATMENT FAILURE IN A CASE OF MULTI-DRUG RESISTANT TUBERCULOSIS (MTB)
Xu, Jun-Chi
Chen, Xin-Nian
Ye, Zhi-Jian
Wu, Mei-Ying
Shi, Cui-Lin
Tang, Pei-Jun
Chen, Hui
Zhu, Xiao-Yan
Song, Hua-Feng
Ping, Xu
SARCOIDOSIS VASCULITIS AND DIFFUSE LUNG DISEASES, 2017, 34 (01) : 97 - 99
[48] Establishment of Adoptive Immunotherapy Transfusion Time of Cytokine-induced Killer Cells
Wu Changping
Deng Haifeng
Jiang Jingting
JOURNAL OF INTERNATIONAL TRANSLATIONAL MEDICINE, 2013, 1 (03): : 79 - 84
[49] Immunotherapy with Cytokine-Induced Killer Cells in Metastatic Renal Cell Carcinoma
Su, Xiaosan
Zhang, Lei
Jin, Liangkun
Ye, Junsong
Guan, Zheng
Chen, Rui
Guo, Tao
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS, 2010, 25 (04) : 465 - 470
[50] Improving Clinical Manufacturing of IL-15 Activated Cytokine-Induced Killer (CIK) Cells
Bremm, Melanie
Pfeffermann, Lisa-Marie
Cappel, Claudia
Katzki, Verena
Erben, Stephanie
Betz, Sibille
Quaiser, Andrea
Merker, Michael
Bonig, Halvard
Schmidt, Michael
Klingebiel, Thomas
Bader, Peter
Huenecke, Sabine
Rettinger, Eva
FRONTIERS IN IMMUNOLOGY, 2019, 10

← 1 2 3 4 5 →